Acadia Healthcare reported Q4 2019 revenue of $780.2 million, a 4.9% increase year-over-year. The company experienced a net loss of $11.3 million, or $0.13 per diluted share. U.S. facilities showed improvement, and the company is proceeding with the sale of its U.K. business.
Revenue for the fourth quarter was $780.2 million, up 4.9% from Q4 2018.
Net loss attributable to Acadia stockholders was $11.3 million, or $0.13 per diluted share.
U.S. same facility revenue increased 5.5%, driven by increases in patient days and revenue per patient day.
A formal process was launched regarding the sale of the U.K. business.
Acadia provided financial guidance for the full year 2020, including revenue, adjusted EBITDA, and adjusted earnings per diluted share. The company also provided guidance for the first quarter of 2020.